Well if a well rested PR has managed to oversee a 97% drop in the SP I don't think it makes much difference. I suspect you will get another opportunity to follow your "strategy" of buying into yet another CR soon.
I hope I'm wrong but I'm far from convinced they have a deal waiting in the wings for the nod from the FDA
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-50
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.0¢ | $93.94K | 463.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 101248 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 120958 | 10 |
View Market Depth
| Last trade - 12.15pm 10/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |